Wells Messersmith, MD, FACP (Presenter) Associate Professor & Director, GI Medical Oncology University of Colorado Cancer Center Denver, CO
Luis A. Diaz, MD (Chair) Associate Professor of Oncology Johns Hopkins Hospital Baltimore, MD
Estimated amount of time to complete: 1 hour
Colorectal cancer is the third most common cause of death from cancer in the United States, leading to more than 50,000 deaths annually. About one-quarter of patients with colorectal cancer present with metastatic disease at the time of diagnosis and about 50% to 60% of patients with colorectal cancer will eventually develop metastatic disease. Clinical advances have led to better patient outcomes in patients with metastatic colorectal cancer, including the potential for longer-term survival in some patients. However, the availability of multiple treatment options adds to the complexity of developing optimal treatment approaches for each individual patient. Medical oncologists play a key role in ensuring that patients with metastatic colorectal cancer achieve the best possible outcomes. The goal of this continuing medical education activity is to expand the ability of clinicians to select new approaches based on current evidence to optimize outcomes in their patients with metastatic colorectal cancer.
Johns Hopkins Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity. Target Audience
This activity is intended for medical, surgical, and radiation oncologists as well as pathologists, gastroenterologists, nurses, physician assistants, and other healthcare providers interested and involved in the treatment of patients with colorectal cancer.
There are no prerequisites for participating in this activity.
Upon completion of this educational activity, the participant should be able to:
Integrate optimal evidence-based cytotoxic and targeted therapies into individualized treatment plans for patients with metastatic colorectal cancer.
Summarize recent changes to clinical practice guidelines for the treatment of metastatic colorectal cancer.
Explain which biomarker tests are beneficial in guiding treatment selection for patients with metastatic colorectal cancer.
Outline the role of angiogenesis inhibition in improving outcomes for patients with metastatic colorectal cancer.
Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
Wells Messersmith – Grants/Research: Bayer, Genentech, Pfizer, Roche
Luis Diaz – Consultant: Morphotek; Stock: Personal Genome Dx, Inostics
Wells Messersmith – Grants/Research: Bayer, Genentech, GlaxoSmithKline, Millenium, Pfizer, Roche; Consultant: GlaxoSmithKline, Morphoteck
Nancy Kemeny – Grants/Research: Amgen
All other planners have no relationships to disclose.
Disclosure Relationships Relevant to Faculty Presentations:
Wells Messersmith: Grants/Research: Bayer, Genentech, Pfizer, Roche
All other faculty have no relationships relevant to their presentation.
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
No off-label products discussed.
Accreditation Statement: The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Certification Statement: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There is no fee to participate and receive credit.
Nursing, Nurse Practitioner and Physician Assistant Credit Reciprocity
American Nurses Credentialing Center (ANCC) accepts
AMA PRA Category 1 Credit ™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit ™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit ™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hours of Category 1 credit for completing this program.
Commercial Support Statements
Supported by educational grants from Eli Lilly & Company and Bayer HealthCare.
Minimum System Requirements:
• Pentium III, 600 MHz or Equivalent Processor
• 512 MB of RAM
• Windows XP, Vista, or 7
• Mac OS X
• 800x600 Monitor Resolution
• 16-bit Color
• 16 bit Sound Card with Speakers
Please turn off all pop-up blockers to assure access to the educational activity.
Click on the "Start program" icon at the bottom of this page. You may start as a GUEST, but to claim credit, you must be a member. If you are not already registered as a user of this website, visit the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information.
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 60 minutes to complete.
After the program has finished, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. A credit statement/certificate will be awarded for a score of 70% or better and may be printed immediately after passing the post-test.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
CONFIDENTIALITY DISCLAIMER FOR CME CONFERENCE ATTENDEES
I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person’s health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.”
For CME Questions, please contact the CME Office at (410) 955-2959 or e-mail firstname.lastname@example.org.
For CME Certificates, please call (410) 502-9634.
Johns Hopkins University School of Medicine
Office of Continuing Medical Education.
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195
Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME program. CME collects only the information necessary to provide you with the services that you request.
All rights reserved - The Johns Hopkins University School of Medicine.
Please visit www.hopkinscme.edu to view other Johns Hopkins CME activities.